ALIGN TECHNOLOGY INC — Form 8-K
Filed October 28, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 62/100
What the filing says
Align Technology's Board appointed Jennifer L. Davis as President and CEO effective December 31, 2026, succeeding Joseph M. Hogan. Davis, former CEO of Procter & Gamble's Global Healthcare business, will join as CEO-elect and Board member on November 2, 2026, receiving a $1.3M base salary, $2M sign-on bonus, $16.5M equity award (60% MSUs, 40% RSUs over 3-4 years), and 150% target annual bonus. Hogan transitions to a consulting role at $150K annually through December 31, 2027.
Why this rating
Leadership transition is material for governance but company has clear strategy; Davis's consumer healthcare/branding expertise relevant but execution risk remains. Costs moderate relative to $11.1B market cap.
See more from October 28, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.